Trial Profile
Effects of Obeticholic Acid on Hepatic Fatty Acid/Triglyceride Metabolism and Hepatobiliary Detoxification/Elimination in Morbidly Obese and Gallstone Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Obesity
- Focus Biomarker; Pharmacodynamics
- Acronyms OCABSGS
- 14 Apr 2018 Results presented at The International Liver Congress 2018
- 15 Oct 2016 Status changed from recruiting to completed.
- 18 Feb 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.